News about

New Dental Technology Innovation Hub Launched in Delhi to Boost Indigenous Devices

New Dental Technology Innovation Hub Launched in Delhi to Boost Indigenous Devices

Union Minister of State (Independent Charge) for Science and Technology Dr. Jitendra Singh on September 24 inaugurated a new Dental Technology Innovation Hub at the Maulana Azad Institute of Dental Sciences (MAIDS), New Delhi.

| 25/09/2025 | By 224

Anbenitamab Set to Lead as First Bispecific mAb in China's HER2+ Gastric Cancer Market: GlobalData

Anbenitamab Set to Lead as First Bispecific mAb in China's HER2+ Gastric Cancer Market: GlobalData

China’s NMPA has accepted Alphamab Oncology’s NDA for KN026 (Anbenitamab), which could become the first bispecific mAb for HER2-positive gastric and GEJ cancer, according to GlobalData.

| 25/09/2025 | By 376

US FDA Declines Approval for Biogen's Higher-Dose Spinraza in SMA

US FDA Declines Approval for Biogen's Higher-Dose Spinraza in SMA

The decision was relayed via a ‘complete response letter’ to Biogen, which clarified there were no issues with the clinical data behind the new high-dose regimen. Biogen says it will resubmit the application promptly, drawing on information that is already at hand.

| 24/09/2025 | By 186

Vidal Health and Serum Institute Offer Easy Digital Access to HPV Vaccines

Vidal Health and Serum Institute Offer Easy Digital Access to HPV Vaccines

Starting on 1 October, people will be able to use Vidal Health’s online platform to get the HPV vaccine easily and pay cashlessly. The new partnership with Serum Institute of India, the world’s biggest vaccine maker, aims to help the national effort against cervical cancer.

| 24/09/2025 | By 290

Australia Approves Leqembi for Early Alzheimer's Disease Following TGA-Eisai Agreement

Australia Approves Leqembi for Early Alzheimer's Disease Following TGA-Eisai Agreement

The Therapeutic Goods Administration (TGA) of Australia has approved lecanemab (Leqembi), developed collaboratively by BioArctic and Eisai, for the treatment of adult patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (early AD).

| 24/09/2025 | By 196

7 in 10 Pharma Digital Projects Fail Despite Heavy Investments: Vector Study

7 in 10 Pharma Digital Projects Fail Despite Heavy Investments: Vector Study

A new study by Vector Consulting Group has revealed that while Indian pharmaceutical companies are investing heavily in digitalisation, most projects are failing to deliver measurable business outcomes.

| 24/09/2025 | By 439

Lilly Plans to Build USD 6.5 Billion Facility to Manufacture APIs in Texas

Lilly Plans to Build USD 6.5 Billion Facility to Manufacture APIs in Texas

Eli Lilly will invest USD 6.5 billion to set up a new API manufacturing facility in Houston, Texas—its eighth US site since 2020—creating over 4,600 jobs and boosting domestic production of small molecule medicines.

| 24/09/2025 | By 408

ACG Engineering Launches SMARTCOATER X2 at Pharma Pro & Pack 2025

ACG Engineering Launches SMARTCOATER X2 at Pharma Pro & Pack 2025

SMARTCOATER X2, an upgraded version of the SMARTCOATER X.ONE, is designed with a simplified user interface and operations, aiming to increase efficiency and deliver superior output, according to ACG Engineering.

| 24/09/2025 | By 272

GSK to submit label update for Wellcovorin at US FDA's request

GSK to submit label update for Wellcovorin at US FDA's request

GSK will file an sNDA with the US FDA to update Wellcovorin’s label to include Cerebral Folate Deficiency, following the agency’s request under its initiative to repurpose older drugs for chronic conditions.

| 24/09/2025 | By 241

Evonik Expands Excipients Portfolio, Launches MaxiPure Polysorbate 80 for Injectable Formulations

Evonik Expands Excipients Portfolio, Launches MaxiPure Polysorbate 80 for Injectable Formulations

Engineered to meet the stringent demands of modern drug development, Evonik's MaxiPure Polysorbate 80 addresses key challenges such as protein stability, viral inactivation, and the consistent solubilisation of hydrophobic active pharmaceutical ingredients (APIs).

| 24/09/2025 | By 217

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members